<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physio.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Research Foundation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22988445</article-id><article-id pub-id-type="pmc">3439858</article-id><article-id pub-id-type="doi">10.3389/fphys.2012.00364</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Lack of Association of <italic>ACE2</italic> G8790A Gene Mutation with Essential Hypertension in the Chinese Population: A Meta-Analysis Involving 5260 Subjects</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yan-yan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001">*</xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University</institution><country>Nanjing, China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Mariappan Muthuchamy, Texas A&#x00026;M Health Science Center, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ryuichi Morishita, Osaka University, Japan; Scott Earley, Colorado State University, USA; Xin Wu, Texas A&#x00026;M Health Science Center, USA</p></fn><corresp id="fn001">*Correspondence: Yan-yan Li, Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. e-mail: <email xlink:type="simple">lyynjmu123@126.com</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Frontiers in Vascular Physiology, a specialty of Frontiers in Physiology.</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>9</month><year>2012</year></pub-date><pub-date pub-type="collection"><year>2012</year></pub-date><volume>3</volume><elocation-id>364</elocation-id><history><date date-type="received"><day>22</day><month>6</month><year>2012</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012 Li.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://www.frontiersin.org/licenseagreement"><license-p>This is an open-access article distributed under the terms of the <uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</uri>, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.</license-p></license></permissions><abstract><p><bold>Background:</bold> The <italic>angiotensin converting enzyme 2</italic> (<italic>ACE2</italic>) G8790A gene polymorphism has been associated with the susceptibility to essential hypertension (EH), but the results are disputable. <bold>Objective and Methods:</bold> To investigate the relationship between the <italic>ACE2</italic> G8790A gene polymorphism and EH, eight separate studies with 5260 subjects were meta-analyzed. The pooled odds ratio (OR) and its corresponding 95% confidence interval (CI) were calculated by a random effect model. <bold>Results:</bold> In the <italic>ACE2</italic> G8790A gene polymorphism and EH meta-analysis in a Chinese population, no significant association was found between the <italic>ACE2</italic> G8790A gene polymorphism and EH (OR: 1.03, 95% CI: 0.87&#x02013;1.21, <italic>P</italic>&#x02009;=&#x02009;0.76). In the stratified analysis by gender, no significant risk was found among males (OR: 1.06, 95% CI: 0.82&#x02013;1.36, <italic>P</italic>&#x02009;=&#x02009;0.66) or females (OR: 0.98, 95% CI: 0.77&#x02013;1.24, <italic>P</italic>&#x02009;=&#x02009;0.85). Under a dominant model of inheritance in the female subgroup, the pooled OR for the GG/GA&#x02009;+&#x02009;AA value was 1.01 (95% CI: 0.82&#x02013;1.25, <italic>P</italic>&#x02009;=&#x02009;0.92). Under a recessive model of inheritance in the female subgroup, the pooled OR for the AA/AG&#x02009;+&#x02009;GG value was 0.93 (95% CI: 0.50&#x02013;1.73, <italic>P</italic>&#x02009;=&#x02009;0.83). <bold>Conclusion:</bold> The current meta-analysis suggested that the <italic>ACE2</italic> G8790A gene polymorphism might not be related to the increased EH risk in the Chinese population.</p></abstract><kwd-group><kwd>angiotensin converting enzyme 2</kwd><kwd>gene polymorphism</kwd><kwd>G8790A</kwd><kwd>hypertension</kwd><kwd>meta-analysis</kwd></kwd-group><counts><fig-count count="6"/><table-count count="3"/><equation-count count="0"/><ref-count count="25"/><page-count count="7"/><word-count count="4148"/></counts></article-meta></front><body><sec><title>Introduction</title><p>The gene polymorphism of <italic>angiotensin converting enzyme 2</italic> (<italic>ACE2</italic>) has been associated with the pathogenesis of essential hypertension (EH). <italic>ACE2</italic>, a homolog of <italic>ACE</italic> discovered by Donoghue et al. (<xref ref-type="bibr" rid="B5">2000</xref>) and Tipnis et al. (<xref ref-type="bibr" rid="B18">2000</xref>), has a catalytic domain 42% similar with that of <italic>ACE</italic>. <italic>ACE2</italic> is mainly expressed in the kidney, but is also found in the heart, testes, blood vessels, lungs, brain, nose, mouth, gastrointestinal tissues, and so on. In contrast to <italic>ACE</italic>, <italic>ACE2</italic> is not obviously expressed in any of these tissues, but is mostly expressed in endothelial cells. <italic>ACE2</italic> is located in the Xp22 chromosome with 18 exons. <italic>ACE2</italic> hydrolyzes angiotensin (Ang) I and generates Ang 1&#x02013;9. Ang 1&#x02013;9 is resolved into Ang 1&#x02013;7, whose physiological activities are contrary to Ang II. Ang 1&#x02013;7 can relax vessels, decrease the blood pressure, as well as inhibit the proliferation of cardiac myocytes, myocardium fibroblasts, and vascular smooth muscle cells. Hence, <italic>ACE2</italic> and <italic>ACE</italic> exhibit mutual antagonism. <italic>ACE2</italic> is supposed to demonstrate a protective function in the regulation of heart and blood pressures. Consequently, <italic>ACE2</italic> may become a new treatment target for cardiovascular diseases.</p><p><italic>Angiotensin converting enzyme 2 gene</italic>, located in X chromosome, spans &#x0223c;2.4&#x02009;kb and contains 18 exons. The G8790A polymorphism was at fourth base in the third intron adjacent to exon. The 8790th base guanine (G) was substituted by adenine (A) which resulted in the mRNA montage changes and <italic>ACE2</italic> gene expression.</p><p>The association of the <italic>ACE2</italic> G8790A gene polymorphism with EH significantly differed among various ethnicities. Benjafield et al. (<xref ref-type="bibr" rid="B1">2004</xref>) have found no association between the <italic>ACE2</italic> G8790A gene polymorphism and EH in Australian individuals by a polymerase chain reaction-restriction fragment length polymorphism analysis (Benjafield et al., <xref ref-type="bibr" rid="B1">2004</xref>). Zhong et al. (<xref ref-type="bibr" rid="B22">2006</xref>) have found that females and individuals carrying only the G allele had significantly higher risks for increased diastolic blood pressure (DBP). The <italic>ACE2</italic> G8790A polymorphism is also concluded to be associated with hypertension in Han-Chinese patients with metabolic syndromes (Zhong et al., <xref ref-type="bibr" rid="B22">2006</xref>). Jiang et al. (<xref ref-type="bibr" rid="B10">2010</xref>) found that the <italic>ACE2</italic> G8790A polymorphism might be associated with EH. They reported that male populations with G allele and female population with GG genotype had higher risk of EH in China (Jiang et al., <xref ref-type="bibr" rid="B10">2010</xref>). However, Si et al. (<xref ref-type="bibr" rid="B17">2009</xref>) reported that the A allele increased the EH risk only in the male Chinese population. They found no significant association of <italic>ACE2</italic> G8790A gene polymorphism and EH in the female Chinese population. Zhou and Yang (<xref ref-type="bibr" rid="B23">2009</xref>) performed a meta-analysis on the <italic>ACE2</italic> G8790A polymorphism with Chinese Han EH and they concluded that <italic>ACE2</italic> G8790A polymorphism might not be genetic risk factor for EH in a Chinese Han population. In contrast, Lu et al. (<xref ref-type="bibr" rid="B13">2012</xref>) also conducted a similar meta-analysis and they found that <italic>ACE2</italic> G8790A polymorphism was probably a genetic risk factor for EH across different ethnic populations in female subjects and in Han-Chinese male subjects.</p><p>The present meta-analysis, which involved 5260 participants, was performed to obtain a more precise and comprehensive estimation of the association between the <italic>ACE2</italic> G8790A gene polymorphism and EH in the Chinese population.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Publication search and inclusion criteria</title><p>The electronic databases PubMed, Embase, Web of Science, China Biological Medicine Database, and China National Knowledge Infrastructure were searched in the current meta-analysis using the medical subject heading &#x0201c;hypertension,&#x0201d; &#x0201c;ACE2,&#x0201d; and &#x0201c;gene polymorphism.&#x0201d; The last research was performed on July 23, 2012. The range of publication years was from 2005 to 2010.</p><p>The inclusion criteria were as follow: (a) evaluation of the association between the <italic>ACE2</italic> G8790A gene polymorphism and EH; and (b) the EH diagnosis was in line with the 1999 EH diagnosis criteria of the World Health Organization as systolic blood pressure (SBP) &#x02265;140&#x02009;mmHg, DBP &#x02265;90&#x02009;mmHg. Secondary hypertension was not included in the present investigation.</p></sec><sec><title>Data extraction</title><p>Data were collected according to a standard protocol. Repeated publications, those that violate any inclusion criterion, and/or those deviating from the Hardy&#x02013;Weinberg equilibrium (HWE) were excluded. If different articles conveyed the same results, the results were considered only once in the current meta-analysis. The information extracted from literature included the name of the first author, year of publication, region, number of genotypes, total number of cases, and controls listed in Tables <xref ref-type="supplementary-material" rid="SM1">S1</xref> and <xref ref-type="supplementary-material" rid="SM2">S2</xref> in Supplementary Material. Given that <italic>ACE2</italic> is located in the X chromosome, the meta-analysis was classified into male and female subgroups.</p></sec><sec><title>Statistical methods</title><p>The strength of association between the <italic>ACE2</italic> G8790A gene polymorphism and EH was assessed by the odds ratio (OR) corresponding to a 95% confidence interval (CI). The chi-square-based <italic>Q</italic>-test was used to check the heterogeneity assumption (significance set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; Cochran, <xref ref-type="bibr" rid="B2">1968</xref>). Upon determination of heterogeneity among studies, the random-effects model was used to estimate the pooled OR by the DerSimonian and Laird method (DerSimonian and Laird, <xref ref-type="bibr" rid="B4">1986</xref>). Otherwise, the pooled OR was estimated using the fixed-effects model (the Mantel&#x02013;Haenszel method; Mantel and Haenszel, <xref ref-type="bibr" rid="B14">1959</xref>). <italic>I</italic><sup>2</sup> was used to assess the heterogeneity. The lower was the <italic>I</italic><sup>2</sup>, the smaller was the heterogeneity. Fisher&#x02019;s exact test was used to assess the HWE (significance set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). The potential publication bias was estimated by the funnel plot. Egger et al.&#x02019;s (<xref ref-type="bibr" rid="B6">1997</xref>) linear regression test of the natural logarithm scale of the OR (significance set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) was used to assess the funnel plot asymmetry. The STATA 10.0 software (StataCorp, College Station, TX, USA) was used to perform all statistical analyses.</p></sec></sec><sec><title>Results</title><sec><title>Study characteristics and meta-analysis results</title><p>A total of 15 papers were retrieved by the literature search, and eight of the papers fitted the study selection criteria. Of the seven excluded studies, three papers were reviews, three had nothing about the ACE 2 G8790A gene polymorphism, and one was a repeated publication (Zhang et al., <xref ref-type="bibr" rid="B20">2008</xref>). In the female subgroup, four papers deviating from the HWE were excluded (Liu et al., <xref ref-type="bibr" rid="B12">2005</xref>; Niu et al., <xref ref-type="bibr" rid="B15">2007</xref>; Si et al., <xref ref-type="bibr" rid="B17">2009</xref>; Zhang et al., <xref ref-type="bibr" rid="B21">2010</xref>; Figure <xref ref-type="fig" rid="F1">1</xref>). In total, the data from the eight studies were gathered from 3090 men and 2170 women from three ethnicities. There were 2769 EH patients and 2491 controls. In the male subgroup, there were 1670 EH patients and 1420 controls. In the female subgroup, there were 1099 EH patients and 1071 controls. The OR values differed among the eight studies, and some of which approved that the A allele of G8790A increased the EH risk. However, the results of other studies were unclear and had to be integrated to reach a valuable conclusion. The three ethnicities included Han, Dongxiang and Li (Tables <xref ref-type="supplementary-material" rid="SM1">S1</xref> and <xref ref-type="supplementary-material" rid="SM2">S2</xref> in Supplementary Material; Liu et al., <xref ref-type="bibr" rid="B12">2005</xref>; Hang et al., <xref ref-type="bibr" rid="B9">2006</xref>; Yi et al., <xref ref-type="bibr" rid="B19">2006</xref>; Fan et al., <xref ref-type="bibr" rid="B7">2007</xref>; Niu et al., <xref ref-type="bibr" rid="B15">2007</xref>; Si et al., <xref ref-type="bibr" rid="B17">2009</xref>; Jiang et al., <xref ref-type="bibr" rid="B10">2010</xref>; Zhang et al., <xref ref-type="bibr" rid="B21">2010</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Flow diagram of articles selection process for <italic>ACE2</italic> G8790A gene polymorphism and EH risk meta-analysis</bold>.</p></caption><graphic xlink:href="fphys-03-00364-g001"/></fig><p>In the present <italic>ACE2</italic> G8790A gene polymorphism and EH meta-analysis, under an allelic genetic model of inheritance, the distribution of the A allelic frequency was 0.496 for the EH group and 0.489 for the control. Figure <xref ref-type="fig" rid="F2">2</xref> shows the summary OR of the distribution of the A allelic frequency, which was 1.03 (95% CI: 0.87&#x02013;1.21) by the random effects model. The heterogeneity comparisons significantly differed (<italic>P</italic>&#x02009;=&#x02009;0.003, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;61.0%), but the EH and control groups did not (<italic>P</italic>&#x02009;=&#x02009;0.76; Table <xref ref-type="table" rid="T1">1</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Forest plot of EH associated with ACE2 G8790A gene polymorphism under an allelic genetic model stratified by gender (distribution of A allelic frequency of ACE2 gene)</bold>.</p></caption><graphic xlink:href="fphys-03-00364-g002"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Summary of meta-analysis of association of <italic>ACE2</italic> G8790A gene polymorphism and EH risk in the Chinese population</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Gender</th><th align="left" rowspan="1" colspan="1">Pooled OR (95% CI)</th><th align="left" rowspan="1" colspan="1"><italic>Z</italic> (<italic>P</italic>)</th><th align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Allelic genetic model</td><td align="left" rowspan="1" colspan="1">1.03 (0.87&#x02013;1.21)</td><td align="left" rowspan="1" colspan="1">0.31 (<italic>P</italic>&#x02009;=&#x02009;0.76)</td><td align="left" rowspan="1" colspan="1">61.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Male subgroup</td><td align="left" rowspan="1" colspan="1">1.06 (0.82&#x02013;1.36)</td><td align="left" rowspan="1" colspan="1">0.44 (<italic>P</italic>&#x02009;=&#x02009;0.66)</td><td align="left" rowspan="1" colspan="1">61.0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Female subgroup</td><td align="left" rowspan="1" colspan="1">0.98 (0.77&#x02013;1.24)</td><td align="left" rowspan="1" colspan="1">0.18 (<italic>P</italic>&#x02009;=&#x02009;0.85)</td><td align="left" rowspan="1" colspan="1">69.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Dominant genetic model for female</td><td align="left" rowspan="1" colspan="1">1.01 (0.82&#x02013;1.25)</td><td align="left" rowspan="1" colspan="1">0.10 (<italic>P</italic>&#x02009;=&#x02009;0.92)</td><td align="left" rowspan="1" colspan="1">50.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Recessive genetic model for female</td><td align="left" rowspan="1" colspan="1">0.93 (0.501&#x02013;1.73)</td><td align="left" rowspan="1" colspan="1">0.22 (<italic>P</italic>&#x02009;=&#x02009;0.83)</td><td align="left" rowspan="1" colspan="1">85.5</td></tr></tbody></table><table-wrap-foot><p><italic>CI, confidence interval; OR, odds ratio; Allelic genetic model: distribution of A allelic frequency of <italic>ACE2</italic> gene; Dominant genetic model: GG/GA&#x02009;+&#x02009;AA; Recessive genetic model: AA/GA&#x02009;+&#x02009;GG</italic>.</p></table-wrap-foot></table-wrap><p>The summary OR of the distribution frequency of the A allele in the male subgroup was 1.06 (95% CI: 0.82&#x02013;1.36), as shown in Figure <xref ref-type="fig" rid="F2">2</xref>. In this subgroup, the distribution of the A allelic frequency was 0.469 for the EH group and 0.449 for the control. The heterogeneity among the eight studies significantly differed (<italic>P</italic>&#x02009;=&#x02009;0.01, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;61.0%), but the EH and control groups did not (<italic>P</italic>&#x02009;=&#x02009;0.66; Table <xref ref-type="table" rid="T1">1</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>).</p><p>The summary OR of the distribution frequency of the A allele in the female subgroup was 0.98 (95% CI: 0.77&#x02013;1.24), as shown in Figure <xref ref-type="fig" rid="F2">2</xref>. In this subgroup, the distribution of the A allelic frequency was 0.516 for the EH group and 0.516 for the control. The heterogeneity among the four studies also significantly differed (<italic>P</italic>&#x02009;=&#x02009;0.02, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;69.2%), but the EH and control groups did not (<italic>P</italic>&#x02009;=&#x02009;0.85; Table <xref ref-type="table" rid="T1">1</xref>; Figure <xref ref-type="fig" rid="F2">2</xref>).</p><p>Under a dominant model of inheritance in the female subgroup, the GG/GA&#x02009;+&#x02009;AA value was 0.317 for the EH group and 0.314 for the control. The pooled OR for the GG/GA&#x02009;+&#x02009;AA value was 1.01 (95% CI: 0.82&#x02013;1.25, <italic>P</italic><sub>heterogeneity</sub>&#x02009;=&#x02009;0.11, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;50.7%). The association between the <italic>ACE2</italic> G8790A gene polymorphism and EH in the women was not significant (<italic>P</italic>&#x02009;=&#x02009;0.92; Figure <xref ref-type="fig" rid="F3">3</xref>; Table <xref ref-type="table" rid="T1">1</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Forest plot of the dominant genetic model of EH associated with <italic>ACE2</italic> G8790A gene polymorphism in female population (GG/GA&#x02009;+&#x02009;AA value of angiotensin converting enzyme 2 gene)</bold>.</p></caption><graphic xlink:href="fphys-03-00364-g003"/></fig><p>Under a recessive model of inheritance in the female subgroup, the AA/AG&#x02009;+&#x02009;GG value was 0.375 for the EH group and 0.373 for the control. The pooled OR for the AA/AG&#x02009;+&#x02009;GG value was 0.93 (95% CI: 0.50&#x02013;1.73, <italic>P</italic><sub>heterogeneity</sub>&#x02009;=&#x02009;0.0001, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;85.5%). There was no significant association between the <italic>ACE2</italic> G8790A gene polymorphism and EH in the women (<italic>P</italic>&#x02009;=&#x02009;0.83; Figure <xref ref-type="fig" rid="F4">4</xref>; Table <xref ref-type="table" rid="T1">1</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Forest plot of the recessive genetic model of essential hypertension associated with <italic>ACE2</italic> G8790A gene polymorphism in female population (AA/GA&#x02009;+&#x02009;GG value of angiotensin converting enzyme 2 gene)</bold>.</p></caption><graphic xlink:href="fphys-03-00364-g004"/></fig><p>Meta-regression was conducted to explore the potential sources of heterogeneity in the male subgroup under the allelic genetic model of inheritance. The confounding factors included the publication year, study region, ethnicity, G genotype number of EH group sample size (G1), and G genotype number of control group sample size (G0). All these confounding factors could explain the heterogeneity (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), but publication year was the most important (<italic>P</italic>&#x02009;=&#x02009;0.017; Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><bold>The meta-regression results among eight studies in the male subgroup under the allelic genetic model</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Item</th><th align="left" rowspan="1" colspan="1">Coefficient</th><th align="left" rowspan="1" colspan="1">Standard error</th><th align="left" rowspan="1" colspan="1"><italic>T</italic> value</th><th align="left" rowspan="1" colspan="1"><italic>P</italic> value</th><th align="left" rowspan="1" colspan="1">95% Confidence interval</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Weight</td><td align="left" rowspan="1" colspan="1">&#x02212;0.1845581</td><td align="left" rowspan="1" colspan="1">0.014793</td><td align="left" rowspan="1" colspan="1">&#x02212;12.48</td><td align="left" rowspan="1" colspan="1">0.051</td><td align="left" rowspan="1" colspan="1">&#x02212;0.3725206 to 0.0034044</td></tr><tr><td align="left" rowspan="1" colspan="1">Publication year</td><td align="left" rowspan="1" colspan="1">&#x02212;0.5106332</td><td align="left" rowspan="1" colspan="1">0.0132544</td><td align="left" rowspan="1" colspan="1">&#x02212;38.53</td><td align="left" rowspan="1" colspan="1">0.017<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="left" rowspan="1" colspan="1">&#x02212;0.6790462 to &#x02212;0.3422202</td></tr><tr><td align="left" rowspan="1" colspan="1">Region</td><td align="left" rowspan="1" colspan="1">&#x02212;0.8178791</td><td align="left" rowspan="1" colspan="1">0.0265906</td><td align="left" rowspan="1" colspan="1">&#x02212;30.76</td><td align="left" rowspan="1" colspan="1">0.021<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="left" rowspan="1" colspan="1">&#x02212;1.155745 to &#x02212;0.480013</td></tr><tr><td align="left" rowspan="1" colspan="1">G genotype number of EH group size</td><td align="left" rowspan="1" colspan="1">0.0111473</td><td align="left" rowspan="1" colspan="1">0.0005284</td><td align="left" rowspan="1" colspan="1">21.10</td><td align="left" rowspan="1" colspan="1">0.030<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="left" rowspan="1" colspan="1">0.0044336 to 0.017861</td></tr><tr><td align="left" rowspan="1" colspan="1">Ethnicity</td><td align="left" rowspan="1" colspan="1">&#x02212;0.3915033</td><td align="left" rowspan="1" colspan="1">0.0197832</td><td align="left" rowspan="1" colspan="1">&#x02212;19.79</td><td align="left" rowspan="1" colspan="1">0.032<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="left" rowspan="1" colspan="1">&#x02212;0.6428729 to &#x02212;0.1401337</td></tr><tr><td align="left" rowspan="1" colspan="1">G genotype number of control group size</td><td align="left" rowspan="1" colspan="1">&#x02212;0.0156601</td><td align="left" rowspan="1" colspan="1">0.0007113</td><td align="left" rowspan="1" colspan="1">&#x02212;22.02</td><td align="left" rowspan="1" colspan="1">0.029<xref ref-type="table-fn" rid="tfn1">*</xref></td><td align="left" rowspan="1" colspan="1">&#x02212;0.0246984 to &#x02212;0.0066219</td></tr><tr><td align="left" rowspan="1" colspan="1">Cons</td><td align="left" rowspan="1" colspan="1">1028.613</td><td align="left" rowspan="1" colspan="1">26.69087</td><td align="left" rowspan="1" colspan="1">38.54</td><td align="left" rowspan="1" colspan="1">0.017</td><td align="left" rowspan="1" colspan="1">689.4735 to 1367.753</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><p><italic>*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05</italic>.</p></fn><p><italic>Coefficient: regression coefficient</italic>.</p><p><italic>The regression coefficients are the estimated increase in the lnOR per unit increase in the covariates. Cons, constant item</italic>.</p></table-wrap-foot></table-wrap><p>In the subsection analysis stratified by the publication year, Subsection 1 was defined as publication year ranging from 2005 to 2007. Studies with publication year ranging from 2009 to 2010 were defined as Subsection 2. In Subsection one of five studies, the pooled OR was 1.16 (95% CI: 0.95&#x02013;1.40, <italic>P</italic><sub>heterogeneity</sub>&#x02009;=&#x02009;0.20, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;33.8%). In Subsection 2 of three studies, the pooled OR was 0.74 (95% CI: 0.31&#x02013;1.79, <italic>P</italic><sub>heterogeneity</sub>&#x02009;=&#x02009;0.02, <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;74.9%). The subsection analysis indicated that the heterogeneity in Subsection 2 was higher than that in Subsection 1. Therefore, studies on Subsection 2 need further improvement (Table <xref ref-type="table" rid="T3">3</xref>; Figure <xref ref-type="fig" rid="F5">5</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><bold>Subsection analysis summary of the allelic genetic model stratified by publication year in the male subgroup</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Subsection</th><th align="left" rowspan="1" colspan="1">Studies number</th><th align="left" rowspan="1" colspan="1">Weight (%)</th><th align="left" rowspan="1" colspan="1">Pooled OR (95% CI)</th><th align="left" rowspan="1" colspan="1"><italic>Z</italic> (<italic>P</italic>)</th><th align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Subsection 1</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">77.46</td><td align="left" rowspan="1" colspan="1">1.16 (0.95&#x02013;1.40)</td><td align="left" rowspan="1" colspan="1">1.47 (<italic>P</italic>&#x02009;=&#x02009;0.14)</td><td align="left" rowspan="1" colspan="1">33.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Subsection 2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">22.54</td><td align="left" rowspan="1" colspan="1">0.74 (0.31&#x02013;1.79)</td><td align="left" rowspan="1" colspan="1">0.66 (<italic>P</italic>&#x02009;=&#x02009;0.51)</td><td align="left" rowspan="1" colspan="1">74.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Whole population</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">100.0</td><td align="left" rowspan="1" colspan="1">1.06 (0.82&#x02013;1.36)</td><td align="left" rowspan="1" colspan="1">0.44 (<italic>P</italic>&#x02009;=&#x02009;0.66)</td><td align="left" rowspan="1" colspan="1">61.0</td></tr></tbody></table><table-wrap-foot><p><italic>Subsection 1: published before 2007</italic>.</p><p><italic>Subsection 2: published after 2009</italic>.</p></table-wrap-foot></table-wrap><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Forest plot of EH associated with <italic>ACE2</italic> G8790A gene polymorphism stratified by publication year in male subgroup (distribution of A allelic frequency of <italic>ACE2</italic> gene)</bold>.</p></caption><graphic xlink:href="fphys-03-00364-g005"/></fig></sec><sec><title>Bias diagnostics</title><p>No visual evidence of publication bias was found from the funnel plot (Figure <xref ref-type="fig" rid="F6">6</xref>). There was also no significant difference in the Egger&#x02019;s test under the allelic genetic model, which implied that the publication bias was low in the current meta-analysis (<italic>P</italic>&#x02009;=&#x02009;0.658, <italic>T</italic>&#x02009;=&#x02009;0.46).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Funnel plot for studies of the association of essential hypertension and ACE2 G8790A gene polymorphism (distribution of A allelic frequency of <italic>ACE2</italic> gene)</bold>. The horizontal and vertical axis correspond to the OR and confidence limits. OR, odds ratio; SE, standard error.</p></caption><graphic xlink:href="fphys-03-00364-g006"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Essential hypertension is a complex disease caused by a combination of genetic and environmental factors. Crackower et al. (<xref ref-type="bibr" rid="B3">2002</xref>) have found that although the gene knockout of <italic>ACE2</italic> does not affect blood pressure regulation, the serum Ang II level significantly increases. The cardiovascular and renal effects of Ang II are the most important long-term blood pressure regulation mechanisms. They have also found that <italic>ACE2</italic> knockout mice exhibit the cardiac abnormalities similar with cardiac stunning in humans.</p><p>The G8790A gene polymorphism of <italic>ACE2</italic> is the restriction enzyme cutting site located on the fourth base of the third intron. The code is ranked as rs2285666 in the United States Biotechnology Information Center. mRNA and protein expression levels change in cardiovascular diseases and diabetes mellitus (DM; Ribeiro-Oliveira et al., <xref ref-type="bibr" rid="B16">2008</xref>). Hence, the G8790A gene polymorphism may participate in the onset of such illnesses as hypertension, cardiac dysfunction, and DM. The G8790A gene polymorphism is situated in the intron adjoined to the extron, suggesting that this locus could alter mRNA alternate splicing and affect <italic>ACE2</italic> gene expression. The latter led to changes in the serum content of Ang 1&#x02013;7 that inhibited vasoconstriction and cell proliferation (Kramkowski et al., <xref ref-type="bibr" rid="B11">2006</xref>).</p><p>Given the location of the <italic>ACE2</italic> gene in X chromosomes, the association of the G8790A gene polymorphism and EH was classified and analyzed according to gender. In the present meta-analysis, under the premise that age and gender factors were controlled, no significant association was found between the <italic>ACE2</italic> G8790A gene polymorphism and EH under allelic, dominant, and recessive genetic models. There was no significant difference between the EH and control groups in either male or female subgroups. The current meta-analysis suggested that the A allele of the <italic>ACE2</italic> G8790A gene polymorphism might not be related to increased risk for EH.</p><p>In the meta-regression of the confounding factor, the publication year was considered as the most important heterogeneity source. The publication year before 2007 indicated lower heterogeneity, and suggested that the early studies have the smaller heterogeneity than the latter studies.</p><p>The results of the current research conformed to those of Zhou and Yang (<xref ref-type="bibr" rid="B23">2009</xref>) who meta-analyzed the <italic>ACE2</italic> G8790A gene polymorphism and EH in a Chinese Han population. The <italic>ACE2</italic> G8790A gene polymorphism might not be a genetic risk factor for EH in the said population. However, not all of the included studies have followed the HWE. For instance, the study of Liu et al. (<xref ref-type="bibr" rid="B12">2005</xref>) has deviated from the HWE. Hence, this study was excluded in the current meta-analysis. In addition, three genetic models, namely, allelic, dominant, and recessive genetic models, were adopted in the present study to analyze the research results. In contrast, only the allelic genetic model was used in Zhou&#x02019;s work. Regarding Lu&#x02019;s et al. (<xref ref-type="bibr" rid="B13">2012</xref>) work, the limitation also existed. The studies against HWE were also included in the female subgroup in their meta-analysis (Liu et al., <xref ref-type="bibr" rid="B12">2005</xref>; Niu et al., <xref ref-type="bibr" rid="B15">2007</xref>; Si et al., <xref ref-type="bibr" rid="B17">2009</xref>; Zhang et al., <xref ref-type="bibr" rid="B21">2010</xref>). Moreover, another included study was not associated with EH but orthostatic hypertension (Fan et al., <xref ref-type="bibr" rid="B8">2009</xref>). Given these limitations, Lu&#x02019;s conclusion seemed not credible.</p><p>In conclusion, the current meta-analysis suggested that the <italic>ACE2</italic> G8790A gene polymorphism was not associated with susceptibility to EH in the Chinese population. Further studies should use higher investigation sample sizes. Given the relatively small sample size used in the present study, further research should be performed to test the abovementioned conclusion.</p></sec><sec><title>Conflict of Interest Statement</title><p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at <uri xlink:type="simple" xlink:href="http://www.frontiersin.org/Vascular_Physiology/10.3389/fphys.2012.00364/abstract">http://www.frontiersin.org/Vascular_Physiology/10.3389/fphys.2012.00364/abstract</uri></p><supplementary-material content-type="local-data" id="SM1"><label>Supplementary Table S1</label><caption><p><bold>Characteristics of the investigated studies of the association between the ACE2 G8790A gene polymorphism and EH of the male subgroup</bold>.</p></caption><media xlink:href="31838_Li_Presentation1.PDF" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="SM2"><label>Supplementary Table S2</label><caption><p><bold>RT-PCR primers utilized for each gene in the RT-PCR analysis</bold>.</p></caption><media xlink:href="31838_Li_Presentation1.PDF" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>Thank all our colleagues working in the Department of geriatrics, the First Affiliated Hospital of Nanjing Medical University. This work was funded by the National Natural Science Foundation of China (NSFC 81100073 to Dr Yan-yan Li) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjafield</surname><given-names>A. V.</given-names></name><name><surname>Wang</surname><given-names>W. Y.</given-names></name><name><surname>Morris</surname><given-names>B. J.</given-names></name></person-group> (<year>2004</year>). <article-title>No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension</article-title>. <source>Am. J. Hypertens.</source>
<volume>17</volume>, <fpage>624</fpage>&#x02013;<lpage>628</lpage><pub-id pub-id-type="doi">10.1016/j.amjhyper.2004.02.022</pub-id><pub-id pub-id-type="pmid">15233982</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochran</surname><given-names>W. G.</given-names></name></person-group> (<year>1968</year>). <article-title>The effectiveness of adjustment by subclassification in removing bias in observational studies</article-title>. <source>Biometrics</source>
<volume>24</volume>, <fpage>295</fpage>&#x02013;<lpage>313</lpage><pub-id pub-id-type="doi">10.2307/2528036</pub-id><pub-id pub-id-type="pmid">5683871</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crackower</surname><given-names>M. A.</given-names></name><name><surname>Sarao</surname><given-names>R.</given-names></name><name><surname>Oudit</surname><given-names>G. Y.</given-names></name><name><surname>Yagil</surname><given-names>C.</given-names></name><name><surname>Kozieradzki</surname><given-names>I.</given-names></name><name><surname>Scanga</surname><given-names>S. E.</given-names></name><name><surname>Oliveira-dos-Santos</surname><given-names>A. J.</given-names></name><name><surname>da Costa</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Pei</surname><given-names>Y.</given-names></name><name><surname>Scholey</surname><given-names>J.</given-names></name><name><surname>Ferrario</surname><given-names>C. M.</given-names></name><name><surname>Manoukian</surname><given-names>A. S.</given-names></name><name><surname>Chappell</surname><given-names>M. C.</given-names></name><name><surname>Backx</surname><given-names>P. H.</given-names></name><name><surname>Yagil</surname><given-names>Y.</given-names></name><name><surname>Penninger</surname><given-names>J. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Angiotensin-converting enzyme 2 is an essential regulator of heart function</article-title>. <source>Nature</source>
<volume>417</volume>, <fpage>822</fpage>&#x02013;<lpage>828</lpage><pub-id pub-id-type="doi">10.1038/nature00786</pub-id><pub-id pub-id-type="pmid">12075344</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerSimonian</surname><given-names>R.</given-names></name><name><surname>Laird</surname><given-names>N.</given-names></name></person-group> (<year>1986</year>). <article-title>Meta-analysis in clinical trials</article-title>. <source>Control. Clin. Trials</source>
<volume>7</volume>, <fpage>177</fpage>&#x02013;<lpage>188</lpage><pub-id pub-id-type="doi">10.1016/0197-2456(86)90046-2</pub-id><pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donoghue</surname><given-names>M.</given-names></name><name><surname>Hsieh</surname><given-names>F.</given-names></name><name><surname>Baronas</surname><given-names>E.</given-names></name><name><surname>Godbout</surname><given-names>K.</given-names></name><name><surname>Gosselin</surname><given-names>M.</given-names></name><name><surname>Stagliano</surname><given-names>N.</given-names></name><name><surname>Donovan</surname><given-names>M.</given-names></name><name><surname>Woolf</surname><given-names>B.</given-names></name><name><surname>Robison</surname><given-names>K.</given-names></name><name><surname>Jeyaseelan</surname><given-names>R.</given-names></name><name><surname>Breitbart</surname><given-names>R. E.</given-names></name><name><surname>Acton</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1&#x02013;9</article-title>. <source>Circ. Res.</source>
<volume>87</volume>, <fpage>E1</fpage>&#x02013;<lpage>E9</lpage><pub-id pub-id-type="doi">10.1161/01.RES.87.1.1</pub-id><pub-id pub-id-type="pmid">10969042</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M.</given-names></name><name><surname>Davey Smith</surname><given-names>G.</given-names></name><name><surname>Schneider</surname><given-names>M.</given-names></name><name><surname>Minder</surname><given-names>C.</given-names></name></person-group> (<year>1997</year>). <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>Br. Med. J.</source>
<volume>315</volume>, <fpage>629</fpage>&#x02013;<lpage>634</lpage><pub-id pub-id-type="doi">10.1136/bmj.315.7119.1371</pub-id><pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Hui</surname><given-names>R. T.</given-names></name></person-group> (<year>2007</year>). <article-title>Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women</article-title>. <source>Clin. Pharmacol. Ther.</source>
<volume>82</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage><pub-id pub-id-type="doi">10.1038/sj.clpt.6100214</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>X. H.</given-names></name><name><surname>Wang</surname><given-names>Y. B.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>W. L.</given-names></name><name><surname>Song</surname><given-names>X. D.</given-names></name><name><surname>Cheng</surname><given-names>J. Z.</given-names></name><name><surname>Wu</surname><given-names>H. Y.</given-names></name><name><surname>Zhou</surname><given-names>X. L.</given-names></name><name><surname>Hui</surname><given-names>R. T.</given-names></name></person-group> (<year>2009</year>). <article-title>Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients</article-title>. <source>Acta Pharmacol. Sin.</source>
<volume>30</volume>, <fpage>1237</fpage>&#x02013;<lpage>1244</lpage><pub-id pub-id-type="doi">10.1038/aps.2009.110</pub-id><pub-id pub-id-type="pmid">19684612</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Gu</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese</article-title>. <source>J. Hum. Hypertens.</source>
<volume>20</volume>, <fpage>968</fpage>&#x02013;<lpage>971</lpage><pub-id pub-id-type="doi">10.1038/sj.jhh.1002090</pub-id><pub-id pub-id-type="pmid">17024138</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X. B.</given-names></name><name><surname>Zhang</surname><given-names>D. F.</given-names></name><name><surname>Jiang</surname><given-names>W. J.</given-names></name><name><surname>Wang</surname><given-names>S. J.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>D. J.</given-names></name><name><surname>Jiang</surname><given-names>Z. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Association of angiotensin-converting enzyme 2 gene G8790A polymorphism with essential hypertension in Han Chinese</article-title>. <source>Chin. Gen. Prac.</source>
<volume>13</volume>, <fpage>3274</fpage>&#x02013;<lpage>3277</lpage></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramkowski</surname><given-names>K.</given-names></name><name><surname>Mogielnicki</surname><given-names>A.</given-names></name><name><surname>Buczko</surname><given-names>W.</given-names></name></person-group> (<year>2006</year>). <article-title>The physiological significance of the alternative pathways of angiotensin II production</article-title>. <source>J. Physiol. Pharmacol.</source>
<volume>57</volume>, <fpage>529</fpage>&#x02013;<lpage>539</lpage><pub-id pub-id-type="pmid">17229979</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T. B.</given-names></name><name><surname>Shang</surname><given-names>H. P.</given-names></name><name><surname>Zhang</surname><given-names>K. X.</given-names></name><name><surname>Chen</surname><given-names>L. H.</given-names></name><name><surname>Zhu</surname><given-names>X. L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>D. L.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name></person-group> (<year>2005</year>). <article-title>Association of angiotensin I converting enzyme 2 gene polymorphism with essential hypertension in Chinese</article-title>. <source>Chin. J. Med. Genet.</source>
<volume>22</volume>, <fpage>569</fpage>&#x02013;<lpage>571</lpage></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Hui</surname><given-names>R.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects</article-title>. <source>Mol. Biol. Rep.</source>
<volume>39</volume>, <fpage>6581</fpage>&#x02013;<lpage>6589</lpage><pub-id pub-id-type="doi">10.1007/s11033-012-1483-5</pub-id><pub-id pub-id-type="pmid">22297693</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantel</surname><given-names>N.</given-names></name><name><surname>Haenszel</surname><given-names>W.</given-names></name></person-group> (<year>1959</year>). <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J. Natl. Cancer Inst.</source>
<volume>22</volume>, <fpage>719</fpage>&#x02013;<lpage>748</lpage><pub-id pub-id-type="pmid">13655060</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>W. Q.</given-names></name><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>S. Q.</given-names></name><name><surname>Zhou</surname><given-names>W. Y.</given-names></name><name><surname>Qiu</surname><given-names>C. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese</article-title>. <source>Transl. Res.</source>
<volume>150</volume>, <fpage>374</fpage>&#x02013;<lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2007.06.002</pub-id><pub-id pub-id-type="pmid">18022600</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro-Oliveira</surname><given-names>A.</given-names><suffix>Jr.</suffix></name><name><surname>Nogueira</surname><given-names>A. I.</given-names></name><name><surname>Pereira</surname><given-names>R. M.</given-names></name><name><surname>Boas</surname><given-names>W. W.</given-names></name><name><surname>Dos Santos</surname><given-names>R. A.</given-names></name><name><surname>Sim&#x000f5;es e Silva</surname><given-names>A. C.</given-names></name></person-group> (<year>2008</year>). <article-title>The renin-angiotensin system and diabetes: an update</article-title>. <source>Vasc. Health Risk Manag.</source>
<volume>4</volume>, <fpage>787</fpage>&#x02013;<lpage>803</lpage><pub-id pub-id-type="pmid">19065996</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>D. N.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Chui</surname><given-names>T. X.</given-names></name></person-group> (<year>2009</year>). <article-title>Association of angiotensin I converting enzyme 2 gene polymorphism and essential hypertension with diabetes mellitus</article-title>. <source>Chin. J. Pract. Nerv. Dis.</source>
<volume>12</volume>, <fpage>38</fpage>&#x02013;<lpage>40</lpage></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipnis</surname><given-names>S. R.</given-names></name><name><surname>Hooper</surname><given-names>N. M.</given-names></name><name><surname>Hyde</surname><given-names>R.</given-names></name><name><surname>Karran</surname><given-names>E.</given-names></name><name><surname>Christie</surname><given-names>G.</given-names></name><name><surname>Turner</surname><given-names>A. J.</given-names></name></person-group> (<year>2000</year>). <article-title>A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase</article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume>, <fpage>33238</fpage>&#x02013;<lpage>33243</lpage><pub-id pub-id-type="doi">10.1074/jbc.M002615200</pub-id><pub-id pub-id-type="pmid">10924499</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L.</given-names></name><name><surname>Gu</surname><given-names>Y. H.</given-names></name><name><surname>Wang</surname><given-names>X. L.</given-names></name><name><surname>An</surname><given-names>L. Z.</given-names></name><name><surname>Xie</surname><given-names>X. D.</given-names></name><name><surname>Shao</surname><given-names>W.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Fang</surname><given-names>J. R.</given-names></name><name><surname>An</surname><given-names>Y. D.</given-names></name><name><surname>Zhang</surname><given-names>D. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China</article-title>. <source>J. Int. Med. Res.</source>
<volume>34</volume>, <fpage>272</fpage>&#x02013;<lpage>283</lpage><pub-id pub-id-type="pmid">16866021</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H. M.</given-names></name><name><surname>Fan</surname><given-names>X. H.</given-names></name><name><surname>Han</surname><given-names>Y. F.</given-names></name><name><surname>Li</surname><given-names>W. J.</given-names></name><name><surname>Yang</surname><given-names>X. M.</given-names></name><name><surname>Wang</surname><given-names>S. X.</given-names></name><name><surname>Zhou</surname><given-names>X. L.</given-names></name><name><surname>Wu</surname><given-names>H. Y.</given-names></name><name><surname>Hui</surname><given-names>R. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Polymorphism interaction between angiotensin-conversion enzyme 2 gene and angiotensin-conversion enzyme gene on the risk of essential hypertension in women</article-title>. <source>Chin. Circ. J.</source>
<volume>23</volume>, <fpage>355</fpage>&#x02013;<lpage>359</lpage></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Jin</surname><given-names>S. J.</given-names></name><name><surname>Zhou</surname><given-names>D. F.</given-names></name><name><surname>Zhang</surname><given-names>Y. X.</given-names></name><name><surname>Chen</surname><given-names>S. H.</given-names></name><name><surname>Li</surname><given-names>L. J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Xi</surname><given-names>J. L.</given-names></name><name><surname>Chen</surname><given-names>Z. Q.</given-names></name></person-group> (<year>2010</year>). <article-title>Association of angiotensin I converting enzyme 2 gene polymorphism and essential hypertension in Hainan Li Chinese population</article-title>. <source>Chin. J. Gerontol.</source>
<volume>30</volume>, <fpage>1029</fpage>&#x02013;<lpage>1230</lpage></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Ni</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Tepel</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name></person-group> (<year>2006</year>). <article-title>Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome</article-title>. <source>J. Lab. Clin. Med.</source>
<volume>147</volume>, <fpage>91</fpage>&#x02013;<lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.lab.2005.10.001</pub-id><pub-id pub-id-type="pmid">16459167</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J. B.</given-names></name><name><surname>Yang</surname><given-names>J. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension</article-title>. <source>J. Renin Angiotensin Aldosterone Syst.</source>
<volume>10</volume>, <fpage>31</fpage>&#x02013;<lpage>34</lpage><pub-id pub-id-type="doi">10.1177/1470320309103047</pub-id><pub-id pub-id-type="pmid">19286756</pub-id></mixed-citation></ref></ref-list></back></article>